Literature DB >> 2345700

[Therapy of malignant pheochromocytoma using I-131 metaiodobenzylguanidine--report of a case].

H Okazawa1, K Endo, T Saga, Y Watanabe, T Nakai, K Kasagi, J Konishi, M Abe, K Goto, K Nakao.   

Abstract

A 67 year-old-female had multiple metastases to her lung, liver and paraaortic lymph nodes from a post-operative malignant pheochromocytoma. She was treated with 3.7 GBq (100 mCi) of I-131 metaiodobenzylguanidine (MIBG). Metastatic nodules in lung and liver almost disappeared and the secretion of catecholamines decreased than baseline rates. However, major but temporary untoward response, such as hypertension and hyperglycemia, was seen after the I-131 MIBG administration.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2345700

Source DB:  PubMed          Journal:  Nihon Igaku Hoshasen Gakkai Zasshi        ISSN: 0048-0428


  3 in total

1.  Hypertensive crisis due to contrast-enhanced computed tomography in a patient with malignant pheochromocytoma.

Authors:  Sachiko Nakano; Yoshito Tsushima; Ayako Taketomi-Takahashi; Tetsuya Higuchi; Makoto Amanuma; Noboru Oriuchi; Keigo Endo
Journal:  Jpn J Radiol       Date:  2011-07-24       Impact factor: 2.374

2.  Radionuclide therapy of malignant pheochromocytoma with 131I-MIBG.

Authors:  Y Nakabeppu; M Nakajo
Journal:  Ann Nucl Med       Date:  1994-11       Impact factor: 2.668

3.  131I-metaiodobenzylguanidine therapy for malignant pheochromocytoma.

Authors:  H Sakahara; K Endo; T Saga; M Hosono; H Kobayashi; J Konishi
Journal:  Ann Nucl Med       Date:  1994-05       Impact factor: 2.668

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.